Vanguard Global Advisers’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$663K Buy
13,289
+91
+0.7% +$3.84K ﹤0.01% 1957
2026
Q2
$366K Buy
13,198
+2,339
+22% +$55.2K ﹤0.01% 2250
2026
Q1
$234K Buy
+10,859
New +$200K ﹤0.01% 2360

Other funds holding PLSE

Vanguard Global Advisers's PLSE Position: Q3 2026 in Review

Vanguard Global Advisers increased its Pulse Biosciences (PLSE) stake by 0.69% in Q3 2026, buying an estimated $3.84K and bringing the position to 13,289 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Vanguard Global Advisers first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Vanguard Global Advisers held 13,289 shares of Pulse Biosciences worth $663K as of Q3 2026.
  • Vanguard Global Advisers bought 91 Pulse Biosciences shares in Q3 2026, an estimated $3.84K.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1957 holding.
  • Vanguard Global Advisers first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.